Fresenius Medical Care AG & Co. KGaA
FMS Healthcare Medical Care Facilities
Fresenius Medical Care AG & Co. KGaA’s revenue for fiscal 2025 (year ended December 2025) was $22.2 billion, up 6.13% from fiscal 2024.
- Revenue
- −0.49%
- EPS
- −10.6%
- Free cash flow
- −3.47%
- Total debt
- +8.09%
Quarter to September 2026, against a year earlier
Follow FMS
Alert me
Fresenius Medical Care AG & Co. KGaA (FMS) Price to free cash flow
As of 5 November 2026, Fresenius Medical Care AG & Co. KGaA (FMS) trades at a price to free cash flow of 6.1×. Over the past ten years it has ranged from 4.6× (October 2023) to 39.2× (April 2016); the current reading is higher than 14% of that period. That is below the Medical Care Facilities industry median of 16.0× and below the Healthcare sector median of 21.1×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 6.9× | (4.70%) |
| FY2024 | 7.2× | 22.82% |
| FY2023 | 5.9× | (3.03%) |
| FY2022 | 6.1× | (37.43%) |
| FY2021 | 9.7× | 44.71% |
| FY2020 | 6.7× | (51.12%) |
| FY2019 | 13.7× | (13.74%) |
| FY2018 | 15.9× | (24.48%) |
| FY2017 | 21.0× | (8.45%) |
| FY2016 | 23.0× | (7.66%) |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Sep 2026 | 5.8× | (1.94%) |
| Jun 2026 | 5.9× | (2.79%) |
| Mar 2026 | 6.1× | (11.57%) |
| Dec 2025 | 6.9× | (9.23%) |
| 43 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA | 6.1× |
| THC Tenet Healthcare Corporation compare | 6.9× |
| DVA DaVita Inc. compare | 8.4× |
| UHS Universal Health Services, Inc. compare | 10.3× |
| PACS PACS Group, Inc. compare | 17.7× |
| CON Concentra Group Holdings Parent, Inc. compare | 20.2× |
| ENSG The Ensign Group, Inc. compare | 20.6× |
| CHE Chemed Corporation compare | 23.5× |
| EHC Encompass Health Corporation compare | 32.4× |
| Medical Care Facilities industry median | 16.0× |
| Healthcare sector median | 21.1× |
| Market median | 14.1× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on FMS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement